These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 26413012)
1. Primary Prevention of Sudden Cardiac Death in Adults with Transposition of the Great Arteries: A Review of Implantable Cardioverter-Defibrillator Placement. Sodhi SS; Cedars AM Tex Heart Inst J; 2015 Aug; 42(4):309-18. PubMed ID: 26413012 [TBL] [Abstract][Full Text] [Related]
2. Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries? Wheeler M; Grigg L; Zentner D Congenit Heart Dis; 2014; 9(4):326-32. PubMed ID: 24151816 [TBL] [Abstract][Full Text] [Related]
3. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry. Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482 [TBL] [Abstract][Full Text] [Related]
4. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Khairy P; Harris L; Landzberg MJ; Fernandes SM; Barlow A; Mercier LA; Viswanathan S; Chetaille P; Gordon E; Dore A; Cecchin F Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):250-7. PubMed ID: 19808416 [TBL] [Abstract][Full Text] [Related]
5. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116 [TBL] [Abstract][Full Text] [Related]
6. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter-Defibrillator Failure and Currently Available Options. Elayi CS; Charnigo RJ; Heron PM; Lee BK; Olgin JE Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630173 [No Abstract] [Full Text] [Related]
9. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316 [TBL] [Abstract][Full Text] [Related]
11. The implantable cardioverter-defibrillator: An update. Miller JD; Yousuf O; Berger RD Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255 [TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation. Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988 [TBL] [Abstract][Full Text] [Related]
13. Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators: Insights From the National Cardiovascular Data Registry. Baskar S; Bao H; Minges KE; Spar DS; Czosek RJ Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006542. PubMed ID: 30354291 [TBL] [Abstract][Full Text] [Related]
15. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111 [TBL] [Abstract][Full Text] [Related]
16. End-of-life of implantable defibrillator: are we certain it should always be replaced? Stazi F J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158 [No Abstract] [Full Text] [Related]
17. Implantable cardiac electronic device therapy for patients with a systemic right ventricle. Barracano R; Brida M; Guarguagli S; Palmieri R; Diller GP; Gatzoulis MA; Wong T Heart; 2020 Jul; 106(14):1052-1058. PubMed ID: 32269130 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203 [TBL] [Abstract][Full Text] [Related]
19. Disrupting the Approach to Sudden Cardiac Death: From Vulnerable Ejection Fraction to Vulnerable Patient. Chugh SS Circulation; 2018 Jan; 137(1):7-9. PubMed ID: 29279335 [No Abstract] [Full Text] [Related]
20. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]